This inventor holds 1 USPTO granted patent. Top assignee: Humboldt-Universitaet Zu Berlin. Active years: 1989.
Company Filing History:
Years Active: 1989
Title: Juergen Slapke: Innovator in Pharmaceutical Chemistry
Introduction
Juergen Slapke is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of new compounds.
Latest Patents
Juergen Slapke holds a patent for a novel compound titled "1-(2-hydroxyaryl)-alkane-1-on-oximes-procedure of preparation and use." This patent focuses on the development of 1-(2-hydroxyaryl)-alkane-1-on-oximes with desirable pharmacological properties. The new compounds are characterized by their pharmacologically valuable properties, including anti-asthmatic, anti-anaphylactic, antiphlogistic, antihypertensive, spasmolytic, antirheumatic, and antithrombotic potentials. They are applicable in both human and veterinary medicine for the treatment of asthma bronchiale, allergic diseases, inflammatory and rheumatic diseases, and thrombosis.
Career Highlights
Juergen Slapke is affiliated with Humboldt-Universität zu Berlin, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of pharmacological compounds and their applications in medicine.
Collaborations
Some of his notable coworkers include Hans-Joachim Binte, who is deceased, and Tankred Schewe. Their collaborative efforts have further enriched the research environment at Humboldt-Universität zu Berlin.
Conclusion
Juergen Slapke's innovative work in pharmaceutical chemistry has led to the development of valuable compounds with significant therapeutic potential. His contributions continue to impact the field positively.